[Treatment of inoperable tumors by continuous and prolonged arterial perfusion of an antimitotic association].
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002404:Catheterization; D010478:Chemotherapy, Cancer, Regional Perfusion; D005467:Floxuridine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008937:Mitomycins / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*; D010166:Palliative Care; D010477:Perfusion; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D008937:Mitomycins; D005467:Floxuridine; D014750:Vincristine; D014747:Vinblastine; D005472:Fluorouracil; D008727:Methotrexate
Traitement des tumeurs inopérables par perfusion artérielle continue et prolongée d'une association d'antimitotique.